Heterogeneity in Nectin-4 expression across molecular subtypes of urothelial cancer mediates sensitivity to enfortumab vedotin.

膀胱癌 医学 癌症 癌症研究 福克斯A1 内科学 关贸总协定3 肿瘤科 生物 乳腺癌 基因 转录因子 遗传学
作者
Carissa Chu,Martin Sjöström,Emily A. Egusa,Ewan A. Gibb,Michelle L. Badura,Vadim S. Koshkin,Bradley A. Stohr,Maxwell V. Meng,Raj S. Pruthi,Terence W. Friedlander,Yair Lotan,Peter C. Black,Sima P. Porten,Felix Y. Feng,Jonathan Chou
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:39 (6_suppl): 463-463 被引量:25
标识
DOI:10.1200/jco.2021.39.6_suppl.463
摘要

463 Background: Enfortumab vedotin (EV) is an antibody-drug conjugate (ADC) targeting Nectin-4 (encoded by the PVRL4/NECTIN4 gene ) approved for treatment-refractory metastatic urothelial cancer. Factors that mediate sensitivity or resistance to EV are unknown. In the present study, we sought to 1) examine heterogeneity of NECTIN4 gene expression across molecular subtypes of bladder cancer and 2) determine if Nectin-4 expression mediates EV sensitivity or resistance. Methods: NECTIN4 expression data from seven muscle-invasive bladder cancer clinical cohorts (n = 1912 total patients) were used to compare relative NECTIN4 expression across molecular subtypes. The outcome of the gene expression analysis was relative NECTIN4 expression in the consensus molecular subtypes of bladder cancer. Expression of NECTIN4 was validated in multiple bladder cancer cell lines. NECTIN4 was stably over-expressed or knocked down in basal (TCCSUP and UMUC-3) and luminal (HT-1376, HT-1197 and UMUC-9) bladder cancer cell lines, respectively, and EV dose-response assays were performed, as measured by cell proliferation and clonogenic assays. Results: NECTIN4 expression is heterogenous across molecular subtypes of bladder cancer and significantly enriched in luminal subtypes (p < 0.001). NECTIN4 expression is positively correlated with the luminal markers GATA3, FOXA1, and PPARG across cohorts (Spearman’s rank correlation r = 0.57, p < 0.0001 for GATA3, r = 0.37, p < 0.0001 for FOXA1, and r = 0.56, p < 0.0001 for PPARG). NECTIN4 expression is both necessary and sufficient for EV sensitivity in luminal and basal subtypes of urothelial bladder cancer cells. Downregulation of NECTIN4 led to EV resistance, and EV-resistant cell lines expressed decreased levels of Nectin-4. Conclusions: Results of this pre-clinical study suggest that sensitivity to EV is mediated by expression of NECTIN4, which is significantly enriched in luminal subtypes of bladder cancer. Downregulation of NECTIN4 leads to resistance to EV. These findings have implications for biomarker development, patient selection and the inclusion of molecular subtyping in ongoing and future EV clinical trials. Further investigation into Nectin-4 loss as a mechanism of resistance in patients treated on EV is warranted.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lily发布了新的文献求助20
1秒前
1秒前
白青完成签到,获得积分10
2秒前
搜集达人的应助被obcx采纳,获得10
2秒前
lzl发布了新的文献求助10
2秒前
aaa完成签到,获得积分10
3秒前
wyt完成签到,获得积分10
3秒前
Gyafe发布了新的文献求助10
4秒前
sdkumamon完成签到 ,获得积分10
4秒前
rainbow发布了新的文献求助30
5秒前
闪闪兰发布了新的文献求助30
5秒前
6秒前
7秒前
yuyu完成签到 ,获得积分10
7秒前
7秒前
挚友发布了新的文献求助10
9秒前
小橘子完成签到,获得积分10
9秒前
10秒前
10秒前
黄毛虎发布了新的文献求助10
10秒前
214完成签到,获得积分20
10秒前
11秒前
麒麟才子完成签到,获得积分10
11秒前
觉皇完成签到,获得积分10
11秒前
充电宝的应助被hhhhhhh采纳,获得10
11秒前
相看两厌完成签到,获得积分10
12秒前
吴境发布了新的文献求助10
12秒前
13秒前
13秒前
syvshc的应助被皮卡丘采纳,获得10
13秒前
14秒前
carbon发布了新的文献求助10
14秒前
14秒前
Cat完成签到,获得积分0
15秒前
Mars发布了新的文献求助10
15秒前
KDshyking完成签到,获得积分10
15秒前
KKK完成签到 ,获得积分10
16秒前
dean完成签到,获得积分10
16秒前
腼腆的虔纹完成签到,获得积分20
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187480
求助须知:如何正确求助?哪些是违规求助? 9575554
关于积分的说明 21841909
捐赠科研通 7785230
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559412
邀请新用户注册赠送积分活动 2481898